UTRS News and Press, Minerva Surgical Inc. From 11/07/22

SANTA CLARA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it has changed the date of its previously announced earnings conference call. It wi...

SANTA CLARA, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it will release its third quarter 2022 financial results on Wednesday, November 9, ...

SANTA CLARA, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the H.C. Wainwright 24th ...

After a mixed financial performance in Q2 2022, Minerva Surgical ( NASDAQ: UTRS ), a company focused on uterine healthcare needs of women, chose to lower its full-year guidance, a move that has prompted JPMorgan to downgrade the stock to Underweight. While results were...

SANTA CLARA, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), today reported second quarter financial results for the period ended June 30,...

SANTA CLARA, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. – The Uterine Health Company (Nasdaq: UTRS), focused on the treatment of Abnormal Uterine Bleeding (AUB), today announced their Time To Talk social media campaign and local event series. Abnormal Uter...

SANTA CLARA, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it will release its second quarter 2022 financial results on Tuesday, August 9, 202...

SANTA CLARA, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (“Minerva Surgical” or the “Company”), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), today announced that the board of directors (...

Minerva Surgical, Inc. (UTRS) Q1 2022 Earnings Conference Call May 11, 2022 04:30 PM ET Company Participants Caroline Corner - Investor Relations David Clapper - President and Chief Executive Officer Joel Jung - Chief Financial Officer Conference Call Participants Danielle Antalffy - SVB Secu...

press release (NASDAQ:UTRS): Q1 GAAP EPS of -$0.38 misses by $0.07. Revenue of $10.9M (-7.6% Y/Y) beats by $0.14M. For further details see: GAAP EPS of -$0.38 misses by $0.07, revenue of $10.9M beats by $0.14M